Clark James David's Form 4 filing
CVS Health Corp (CVS) · filed Feb 1, 2022
- Accession no.
- 0001127602-22-002777
- Filed
- Feb 1, 2022
- Trade date
- Jan 28, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $660.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Clark James DavidCIK 0001757584 | Officer (SVP, Cont & Chief Acct Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2022 | Common Stock | MOption exerciseAcquired | +6,059 | $102.26 | +$619,593.34 | 23,556.26 | Direct | |
| Jan 28, 2022 | Common Stock | SSaleDisposed | −6,059 | $109.00 | −$660,431 | 17,497.26 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2022 | Common Stock | MOption exerciseDisposed | −6,059 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.